Omega-3s and Cancer: What You Need to Know

Omega-3s and Cancer: What You Need to Know

✅ The Good

• Heart Health: Lowers triglycerides, protects against sudden cardiac death.
• Brain & Eyes: May help slow memory decline and protect vision with aging.
• Inflammation: Can support joint health and mood.
• During Cancer Treatment: May help prevent weight and muscle loss during chemotherapy.

❓ The Unclear

• Cancer Prevention: No clear evidence that omega-3s lower cancer risk.
• General Cancer Benefit: Research is mixed; some early findings were promising, but large studies have not confirmed protective effects.

⚠️ The Cautions

• Breast & Prostate Cancer: Omega-3 supplements may not help—and could be harmful—in hormone-sensitive cancers.
• Dosage Matters: Safe for most people at 500–1000 mg EPA/DHA daily. Higher doses should only be taken under medical supervision.
• Not a Cancer Cure: Supplements should never replace standard treatment.

🍽️ What You Can Do

• Eat fatty fish (salmon, tuna, sardines, mackerel) 2x per week.
• Add healthy plant sources like walnuts, chia, and flax (though these provide a weaker form of omega-3).
• Talk with your oncologist before starting supplements—especially for breast or prostate cancers.
• Ask if an Omega-3 blood test (Omega-3 Index) might help guide your nutrition plan.

Bottom Line: 🐠 Omega-3s are great for your heart and may help support strength during cancer treatment, but they are not proven to prevent cancer. Always check with your care team before adding supplements to your plan.

Dietary supplements are a multibillion-dollar industry, and omega-3 fatty acids—commonly found in fish oil—remain some of the most studied nutrients. Omega-3s include EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), found in fatty fish like salmon, tuna, and sardines, as well as some supplements. These nutrients play important roles in heart, brain, and eye health, and they have been investigated for their potential impact on cancer prevention and treatment.

What We Know About Omega-3s and General Health

• Heart Health: Decades of research show omega-3s can help lower triglycerides and may protect against sudden cardiac death. Prescription-strength omega-3s are now FDA-approved therapies for patients with very high triglycerides.
• Brain and Eye Health: Studies link omega-3s to healthy aging, reduced risk of age-related macular degeneration, and potentially slower cognitive decline.
• Inflammation: Because EPA and DHA can reduce inflammation, they are often researched for chronic diseases, including arthritis and mood disorders.

Most guidelines, including those from the American Heart Association, recommend eating oily fish twice a week and considering supplementation for people who do not consume enough through diet.

Omega-3s and Cancer: A Mixed Picture

Scientists have long been studying whether omega-3s might lower the risk of cancer or help during treatment. The evidence so far is inconclusive:

• Cancer Risk Reduction: Large population studies and pooled analyses—including more than 700,000 people from multiple trials—have not consistently shown that taking more omega-3s reduces the overall risk of cancer. Some early research suggested potential protective effects for cancers like kidney, breast, and prostate, but these associations have not been confirmed in rigorous controlled trials.
• Hormone-Sensitive Cancers: Evidence now suggests that high-dose fish oil supplements may not be beneficial—and could even be harmful—in patients with hormone-sensitive cancers such as certain breast and prostate cancers. Recent large-scale trials have shown no preventive benefit for fish oil in lowering breast or prostate cancer risk. Because of this, experts advise caution with supplementation in these patient groups.
• During Cancer Treatment: There is hopeful evidence that omega-3s may help support nutrition during cancer treatment. For example, studies in lung cancer patients suggest that fish oil supplements may help reduce muscle and weight loss during chemotherapy (a problem known as cancer cachexia). Maintaining strength and body weight can improve both quality of life and tolerance of treatment.

What Patients Should Keep in Mind

• Diet First: Eating fatty fish (salmon, tuna, sardines, mackerel) remains the best way to get omega-3s. Plant sources such as flaxseed, chia, and walnuts are healthy too, but provide a less potent form of omega-3 (ALA), which the body only partly converts to EPA/DHA.
• Supplements: For most people, a daily supplement of 500–1000 mg of combined EPA/DHA is considered safe, and higher prescription doses may be used under medical supervision for heart health.
• Cancer Patients: Omega-3 supplements should be used with medical guidance, especially for those with breast or prostate cancer, where the benefits remain unclear. Some patients in active treatment may be advised to use them to help maintain weight, but decisions should always be individualized.
• Testing: Doctors can measure omega-3 status with a blood test called the Omega-3 Index. Levels above 8% are linked to better cardiovascular health, though this test is not yet standard of care for cancer guidance.

The Bottom Line

Omega-3 fatty acids are an important part of a healthy diet, especially for heart health and inflammation. Their role in cancer prevention remains uncertain—they should not be viewed as a cancer shield. However, for some patients going through chemotherapy, omega-3s may help maintain strength and body weight.

Patients should focus on a balanced, nutrient-rich diet that includes fish and plant-based omega-3 sources when possible. Before starting omega-3 supplements—particularly if you have or have had breast or prostate cancer—it’s best to consult your oncologist or a registered dietitian specializing in oncology.

Takeaway: Omega-3s are clearly good for heart health, possibly helpful in cancer treatment support (e.g., weight maintenance), but not proven to prevent cancer—and may require extra caution with hormone-sensitive cancers.

 

References:

1. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. Journal of the American Medical Association. 2010;303(3):250-57.
2. Tan JS, Wang JJ, Flood V, Mitchell P. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Archives of Ophthalmology. 2009;127(5):656-65.
3. Yurko-Mauro K, McCarthy D, Bailey-Hall E, Nelson EB, Blackwell A. Results of the MIDAS trial: effects of docosahexaenoic acid on physiological and safety parameters in age-related cognitive decline. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 2009;5(4):P84.
4. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the Seven Countries Study. American Journal of Epidemiology. 1986;124(6):903-15.
5. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779-85.
6. Mayo Clinic Proceedings Contributors Highlight Research Findings about Cardiovascular Benefits Associated with Omega-3 Fatty Acids. Mayo Clinic website. Available at: . Accessed June 13, 2011.
7. Fish and Omega-3 Fatty Acids. American Heart Association website. Available at: . Accessed June 13, 2011.
8. Murphy RA, Mourtzakis M, Chu Q, et al. Nutritional intervention with fish oil provides a benefit over standard of care on weight and skeletal muscle mass in non-small cell lung cancer patients receiving chemotherapy. Cancer [early online publication]. February 28, 2011. DOI: 10.1002/cncr.25709.
9. Brasky TM, Lampe JW, Potter JD et al. Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort, Cancer Epidemiology, Biomarkers & Prevention. 2010; 19(7):1696–708.
10. The Lancet, Vol. 357, pp. 1764-1766, 2001.
11. Wolk A, Larsson SL, Johansson J-E, et al. Long-term fatty fish consumption and renal cell carcinoma incidence in women. Journal of the American Medical Association. 2006;296:1371-1376.
12. MacLean C, Newberry S, Mojica W, et al. Effects of Omega-3 Fatty Acids on Cancer Risk. Journal of the American Medical Association. 2006; 295:403-415.